• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性L-司来吉兰诱导多巴胺摄取载体上调。

Chronic L-deprenyl-induced up-regulation of the dopamine uptake carrier.

作者信息

Wiener H L, Hashim A, Lajtha A, Sershen H

机构信息

Center for Neurochemistry, Nathan S. Kline Institute for Psychiatric Research, Ward's Island, NY 10035.

出版信息

Eur J Pharmacol. 1989 Apr 12;163(1):191-4. doi: 10.1016/0014-2999(89)90418-4.

DOI:10.1016/0014-2999(89)90418-4
PMID:2501102
Abstract

L-Deprenyl is an inhibitor of monoamine oxidase B and dopamine uptake. Chronic L-deprenyl (10 mg/kg i.p., twice weekly for 4 weeks) was shown to inhibit monoamine oxidase B activity by 89%, and also to induce an up-regulation of the [3H]mazindol binding site associated with the striatal dopamine uptake carrier. Scatchard analysis indicated a 56% increase in the maximal number of [3H]mazindol binding sites in chronic L-deprenyl animals, but no effect on the affinity of these binding sites. The ability of L-deprenyl to up-regulate the [3H]mazindol-associated dopamine uptake carrier appears to be a result of its role as a dopamine uptake inhibitor.

摘要

左旋司来吉兰是单胺氧化酶B和多巴胺摄取的抑制剂。慢性给予左旋司来吉兰(腹腔注射10毫克/千克,每周两次,共4周)可使单胺氧化酶B活性抑制89%,还可诱导与纹状体多巴胺摄取载体相关的[3H]麦角吲哚结合位点上调。斯卡查德分析表明,慢性给予左旋司来吉兰的动物中,[3H]麦角吲哚结合位点的最大数量增加了56%,但对这些结合位点的亲和力没有影响。左旋司来吉兰上调[3H]麦角吲哚相关多巴胺摄取载体的能力似乎是其作为多巴胺摄取抑制剂作用的结果。

相似文献

1
Chronic L-deprenyl-induced up-regulation of the dopamine uptake carrier.慢性L-司来吉兰诱导多巴胺摄取载体上调。
Eur J Pharmacol. 1989 Apr 12;163(1):191-4. doi: 10.1016/0014-2999(89)90418-4.
2
Chronic L-deprenyl does not alter the restoration of striatal dopamine in MPTP-lesioned mice.
J Neurosci Res. 1989 Jul;23(3):326-9. doi: 10.1002/jnr.490230312.
3
Inhibition of monoamine oxidase-B by (-)-deprenyl potentiates neuronal responses to dopamine agonists but does not inhibit dopamine catabolism in the rat striatum.(-)-司来吉兰对单胺氧化酶-B的抑制作用增强了大鼠纹状体中神经元对多巴胺激动剂的反应,但并不抑制多巴胺的分解代谢。
J Pharmacol Exp Ther. 1991 Sep;258(3):1019-26.
4
R-(-)-deprenyl (Selegiline, Movergan) facilitates the activity of the nigrostriatal dopaminergic neuron.R-(-)-司来吉兰(Selegiline,Movergan)可促进黑质纹状体多巴胺能神经元的活性。
J Neural Transm Suppl. 1987;25:45-66.
5
Release of endogenous dopamine from rat isolated striatum: effect of clorgyline and (-)-deprenyl.大鼠离体纹状体中内源性多巴胺的释放:氯吉兰和(-)-司来吉兰的作用。
Br J Pharmacol. 1984 Nov;83(3):741-9. doi: 10.1111/j.1476-5381.1984.tb16228.x.
6
Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig.豚鼠体内选择性单胺氧化酶亚型抑制与纹状体细胞外多巴胺
Br J Pharmacol. 2000 Aug;130(8):1992-8. doi: 10.1038/sj.bjp.0703493.
7
The action of (-) deprenyl on monoamine turnover rate in rat brain.(-)去甲丙咪嗪对大鼠脑内单胺周转率的作用。
Adv Biochem Psychopharmacol. 1982;31:211-7.
8
Deprenyl suppresses the oxidant stress associated with increased dopamine turnover.司来吉兰可抑制与多巴胺代谢增加相关的氧化应激。
Ann Neurol. 1989 Nov;26(5):689-90. doi: 10.1002/ana.410260518.
9
Inhibition by deprenyl of dopamine uptake in rat striatum: a possible correlation between dopamine uptake and acetylcholine release inhibition.司来吉兰对大鼠纹状体多巴胺摄取的抑制作用:多巴胺摄取与乙酰胆碱释放抑制之间的可能关联。
Pol J Pharmacol Pharm. 1979 Jul-Aug;31(4):297-307.
10
Comparative effects of amphetamine, phenylethylamine and related drugs on dopamine efflux, dopamine uptake and mazindol binding.苯丙胺、苯乙胺及相关药物对多巴胺流出、多巴胺摄取和吗茚酮结合的比较效应。
J Pharmacol Exp Ther. 1988 Apr;245(1):199-210.

引用本文的文献

1
A Review of Sleep and Its Disorders in Patients with Parkinson's Disease in Relation to Various Brain Structures.帕金森病患者睡眠及其障碍与不同脑结构的关系综述
Front Aging Neurosci. 2016 May 23;8:114. doi: 10.3389/fnagi.2016.00114. eCollection 2016.
2
Evidence that formulations of the selective MAO-B inhibitor, selegiline, which bypass first-pass metabolism, also inhibit MAO-A in the human brain.有证据表明,绕过首过代谢的选择性单胺氧化酶-B抑制剂司来吉兰制剂也能抑制人类大脑中的单胺氧化酶-A。
Neuropsychopharmacology. 2015 Feb;40(3):650-7. doi: 10.1038/npp.2014.214. Epub 2014 Sep 24.
3
Effect of low-dose treatment with selegiline on dopamine transporter (DAT) expression and amphetamine-induced dopamine release in vivo.
司来吉兰低剂量治疗对体内多巴胺转运体(DAT)表达及苯丙胺诱导的多巴胺释放的影响。
Br J Pharmacol. 1999 Feb;126(4):997-1002. doi: 10.1038/sj.bjp.0702389.
4
The vesicular monoamine transporter, in contrast to the dopamine transporter, is not altered by chronic cocaine self-administration in the rat.与多巴胺转运体不同,囊泡单胺转运体不会因大鼠长期自我给药可卡因而发生改变。
J Neurosci. 1996 May 15;16(10):3507-10. doi: 10.1523/JNEUROSCI.16-10-03507.1996.
5
Unaltered [3H]GBR-12935 binding after chronic treatment with dopamine active drugs.多巴胺活性药物长期治疗后[3H]GBR - 12935结合未改变。
Psychopharmacology (Berl). 1990;102(3):291-4. doi: 10.1007/BF02244092.